JPRN-UMIN000008348已完成未知
Clinical effectiveness of daikenchuto (TJ-100) on gastrointestinal symptom after colectomy in colorectal cancer patients with abdominal pain and distention due to a bowel movement disorder. - Clinical effectiveness of daikenchuto (TJ-100) on abdominal pain and distention after cancer resection in the colorectal cancer patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
The numbers of bowel movements per day on postoperative days (PODs) 1, 2, and 6 were significantly lower in the DKT group. The presence of the sensation of incomplete bowel evacuation on PODs 3 and 28 was significantly lower in the DKT group. There were no adverse events due to or suspected to be related to DKT.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •In order to participate in this study, a patient must not meet any of the following criteria.1) Patients with history or at present of chemotherapy and/or radiotherapy for primary disease.2) Patients with lower colectory.3) Patients with concomitant inflammatory bowel disease such as ulcerative colitis and crohn disease.4) Patients with cancerous peritonitis.5) Patients with organic leasion of hepato-biliary-pancreatic (gallstone, hepatitis, pancreatitis)6) Patients with total construction of artificial anus.7) Patients with gastrointestinal hemorrhage, perforation and history of mechanical ileus.8) Patients with serious complications (interstitial pneumonia, diabetes mellitus, heart failure, renal failure, hepatic insufficiency)9) Patients who are administered antiparkinson drug.10) Patients who are pregnant, possibly pregnant, nursing or considering pregnancy.11) Others, patients who are unfit for the study as determined by the attending physician.
研究者
相似试验
已完成
2 期
Effect of Daikenchuto on Postoperative Bowel Motility and on Prevention of Paralytic Ileus after Pancreaticoduodenectomy A Multicenter, Randomized, Placebo-controlled Phase II trialThe patients with periampullary tumors (extrahepatic bile duct tumor, tumors of ampulla of Vater and duodenal tumor) and pancreatic tumors (pancreatic cancer, intraductal papillary mucinous neoplasm of the pancreas, pancreatic endocrine tumor and pancreatic neuroendocrine tumor) of the head of pancreas who are expected to undergo pancreaticoduodenectomyJPRN-UMIN000007975Wakayama Medical University220
已完成
1 期
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)Digestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesAbdominal PainIrritable Bowel SyndromeNCT01890837Tsumura USA40
已完成
不适用
Clinical effectiveness of Daikenchuto (DKT: TJ-100) for abdominal pain or distention in perioperative period of pancreaticoduodenectomyPatients with pancreatic head tumors undergoing pancreaticoduodenectomyJPRN-UMIN000005056Wakayama Medical University1
Unknown
2 期
Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After PancreaticoduodenectomyParalytic IleusNCT01607307Wakayama Medical University220
已完成
不适用
The study of cases administrated Daikenchuto suppositories for paralytic ileus in terminally ill cancer patients.We have prepared Daikenchuto suppositories to administrate for 60 patients who have ileus with nausea or vomiting.JPRN-UMIN000025687Fukushima Medical University, Aizu Medical Center60